Emergency Medicine Doctors in San Francisco, CA Accepting Medicare

237 Emergency Medicine doctors found. Showing 61 - 80

Dr. Zhanna Livshits, M.D. Emergency Medicine - Medical Toxicology Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-1238    Fax: 415-353-1799

Dr. Prathap Sooriyakumaran, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Potrero Ave, San Francisco, CA 94110 Phone: 415-206-8000

Dr. Steven Groke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Mission St Ste 800, San Francisco, CA 94105 Phone: 800-221-5140

Lynn Duong Bui, MD Emergency Medicine - Medical Toxicology Medicare: Accepting Medicare Assignments Practice Location: 1001 Potrero Ave, Rm 1e21, San Francisco, CA 94110 Phone: 415-206-5753    Fax: 415-206-5818

Stephen Howard Hoffman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 Potrero Ave, Rm 1e21, San Francisco, CA 94110 Phone: 415-206-5753    Fax: 415-206-5818

Preston R. Wong, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000

Timothy Hong, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-1000

Kent Russell Olson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Poison Control Ctr, Ucsf Box 1369, San Francisco, CA 94143 Phone: 415-502-6002

Evan D Bloom, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave, Suite 1e21, San Francisco, CA 94110 Phone: 415-206-8111

Mrs. Natalie Terese Snyder, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-1529

Douglas John Evans, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2333 Buchanan St, San Francisco, CA 94115 Phone: 209-342-2300    Fax: 209-524-4240

Robin David Serrahn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2333 Buchanan St, San Francisco, CA 94115 Phone: 209-342-2300    Fax: 209-524-4240

Barbara Jean Kilian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, L126, San Francisco, CA 94143 Phone: 415-353-8388

Thomas G. Padgett, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000

Mai Shimada, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 845 Jackson St, San Francisco, CA 94133 Phone: 415-677-2300

Mr. Roger Stephen Ellis, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Edgehill Way, San Francisco, CA 94127 Phone: 419-681-4404    Fax: 415-375-7500

Dr. Daniel A. Mcdermott, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-1634    Fax: 415-353-1799

John P. Grant, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000

Alan Gjedsted, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000

Michael O'connor, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 845 Jackson St, San Francisco, CA 94133 Phone: 330-493-4443

News Archive

Arsenic and new rice

Amid recent reports of dangerous levels of arsenic being found in some baby rice products, scientists have found a protein in plants that could help to reduce the toxic content of crops grown in environments with high levels of this poisonous metal.

Merrion prepares Phase III study for Orazol in breast cancer treatment

After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

Doctors in the U.S. slow to report an incompetent or unethical colleague

The results of a new survey of doctors in the States suggests that the majority of them, regardless of what they may say, are reluctant to report incompetent or unethical colleagues.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »